MY102212A - Cephalosporin salts and injectable compositions. - Google Patents

Cephalosporin salts and injectable compositions.

Info

Publication number
MY102212A
MY102212A MYPI87002279A MYPI19872279A MY102212A MY 102212 A MY102212 A MY 102212A MY PI87002279 A MYPI87002279 A MY PI87002279A MY PI19872279 A MYPI19872279 A MY PI19872279A MY 102212 A MY102212 A MY 102212A
Authority
MY
Malaysia
Prior art keywords
salts
crystalline
injectable compositions
zwitterion
admixture
Prior art date
Application number
MYPI87002279A
Other languages
English (en)
Inventor
Alan Lipper Robert
Arthur Kaplan Murray
W Hudyma Thomas
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MY102212A publication Critical patent/MY102212A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
MYPI87002279A 1985-08-05 1987-09-29 Cephalosporin salts and injectable compositions. MY102212A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05
GB8618989A GB2179936B (en) 1985-08-05 1986-08-04 Cephalosporin salts and injectable compositions

Publications (1)

Publication Number Publication Date
MY102212A true MY102212A (en) 1992-05-15

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87002279A MY102212A (en) 1985-08-05 1987-09-29 Cephalosporin salts and injectable compositions.

Country Status (34)

Country Link
JP (1) JPH0615548B2 (fr)
KR (1) KR930003121B1 (fr)
AR (1) AR243894A1 (fr)
AT (1) AT390957B (fr)
AU (1) AU597262B2 (fr)
BE (1) BE905219A (fr)
CA (1) CA1284994C (fr)
CH (1) CH675581A5 (fr)
CS (2) CS276849B6 (fr)
CY (1) CY1614A (fr)
DD (2) DD254941A5 (fr)
DE (1) DE3626375A1 (fr)
DK (1) DK162053C (fr)
EG (1) EG18003A (fr)
ES (1) ES2002112A6 (fr)
FI (1) FI84484C (fr)
FR (1) FR2585705B1 (fr)
GB (1) GB2179936B (fr)
GR (1) GR862055B (fr)
HK (1) HK99691A (fr)
HU (1) HU196602B (fr)
IE (1) IE59222B1 (fr)
IL (1) IL79608A (fr)
IT (1) IT1197067B (fr)
LU (2) LU88574I2 (fr)
MY (1) MY102212A (fr)
NL (1) NL8601991A (fr)
OA (1) OA08672A (fr)
PT (1) PT83134B (fr)
SE (1) SE469633B (fr)
SG (1) SG79791G (fr)
SU (1) SU1516013A3 (fr)
YU (1) YU45793B (fr)
ZA (1) ZA865842B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
DE3788279T2 (de) * 1987-06-25 1994-06-16 Banyu Pharma Co Ltd Kristalline cephalosporinzusammensetzungen, verfahren und zwischenprodukte für ihre herstellung.
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (fr) * 1989-03-06 1999-11-16 Murray A. Kaplan Dihydrochlorure de bmy-28142 lyophilise pour usage parenteral
CA2101571A1 (fr) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Dihydrate cristallise d'un sel de cephalosporine dihydrate; compositions injectables a base de ce compose
EP0638573A1 (fr) * 1993-08-10 1995-02-15 Lucky Ltd. Hydrates crystallins d'une céphalosporine et procédé pour leur préparation
ES2298850T3 (es) 2003-12-23 2008-05-16 Sandoz Gmbh Proceso para la produccion de intermedios para utilizar en la sintesis de la cefalosporina.
WO2008056221A2 (fr) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Sel de sulfate cristallin d'antibiotique céphalosporine
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
CA1213882A (fr) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporines
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
EG18003A (en) 1991-08-30
LU86540A1 (fr) 1987-03-06
SU1516013A3 (ru) 1989-10-15
GB2179936B (en) 1989-04-26
AU6069486A (en) 1987-02-12
NL8601991A (nl) 1987-03-02
OA08672A (en) 1989-03-31
DK371886D0 (da) 1986-08-04
DD268395A5 (de) 1989-05-31
PT83134B (pt) 1989-07-31
DK162053B (da) 1991-09-09
CA1284994C (fr) 1991-06-18
DD254941A5 (de) 1988-03-16
AR243894A1 (es) 1993-09-30
GR862055B (en) 1986-12-24
AU597262B2 (en) 1990-05-31
ES2002112A6 (es) 1988-07-16
CY1614A (en) 1992-07-10
DK371886A (da) 1987-02-06
IL79608A0 (en) 1986-11-30
HK99691A (en) 1991-12-13
IE59222B1 (en) 1994-01-26
JPS62103090A (ja) 1987-05-13
FR2585705B1 (fr) 1989-01-13
YU137186A (en) 1987-12-31
HU196602B (en) 1988-12-28
CH675581A5 (fr) 1990-10-15
DK162053C (da) 1992-02-10
FR2585705A1 (fr) 1987-02-06
IT1197067B (it) 1988-11-25
FI863155A0 (fi) 1986-08-01
CS276849B6 (en) 1992-08-12
PT83134A (en) 1986-09-01
AT390957B (de) 1990-07-25
ZA865842B (en) 1987-04-29
IE862078L (en) 1987-02-05
ATA211086A (de) 1990-01-15
GB2179936A (en) 1987-03-18
CS276717B6 (en) 1992-08-12
SG79791G (en) 1991-11-15
YU45793B (sh) 1992-07-20
FI84484C (fi) 1991-12-10
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
IT8621409A0 (it) 1986-08-04
SE469633B (sv) 1993-08-09
IT8621409A1 (it) 1988-02-04
GB8618989D0 (en) 1986-09-17
IL79608A (en) 1991-07-18
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
LU88574I2 (fr) 1995-03-01
SE8603308D0 (sv) 1986-08-04
FI84484B (fi) 1991-08-30
HUT41802A (en) 1987-05-28
DE3626375A1 (de) 1987-02-12
BE905219A (fr) 1987-02-04
FI863155A (fi) 1987-02-06

Similar Documents

Publication Publication Date Title
ES2012948A6 (es) Procedimiento para la preparacion de sales de cefalosporina y composiciones inyectables
MY102212A (en) Cephalosporin salts and injectable compositions.
SE8605063D0 (sv) Derivatives of cyclohexane
ATE36541T1 (de) Stabile sulpho-adenosyl-l-methionin (same)-salze, im besonderen geeignet fuer orale pharmazeutische verwendung.
IE862005L (en) Preparation of oxathiazinone derivative
AR248407A1 (es) Un procedimiento para la preparacion de la forma monohidratada cristalina de una 1-carbacefalosporina.
Tagaki et al. The syntheses and hydrolyses of p-substituted phenyl phosphosulfates
MY116452A (en) Cephalosporin salts and injectable compositions
US4235900A (en) Cephradine compositions
DK251284D0 (da) Substituerede 1,2,3-triazino(4',5'.4,5)thieno(2,3-b)-quinolin-4(3h)-oner eller syreadditionssalte deraf og deres fremstilling
JPS6263597A (ja) アスコルビン酸リン酸エステルマグネシウム水溶液のおり防止法
ES8609208A1 (es) Procedimiento de preparacion de p-aminofenoles
JPS5734026A (en) Production of high-purity potassium fluorotantalate
JPS57149229A (en) Frozen fibrinogen preparation
ES550972A0 (es) Un procedimiento para preparar nuevos derivados de imidiazol.
JPS5653658A (en) Pharmaceutical composition having diuretic and hypotensive activity
JPS5531028A (en) Injection
JPS5795827A (en) Manufacture of high purity lithium carbonate
KR920000787A (ko) 결정성 폴리펩티드
ES8602789A1 (es) Procedimiento para preparar derivados de 14-hidroxiimino- eburnano racemicos y opticamente activos
JPS54103892A (en) Stable uric acid standard solution
GB1530166A (en) Adenine derivatives
JPS5547639A (en) Preparation of alkylanthraquinone
JPS5675449A (en) Precipitation of anthraquinone
JPS5592696A (en) Reagent for detection of peroxidase